Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Seres Therapeutics Inc. (MCRB)

3.51   -0.05 (-1.4%) 02-14 16:00
Open: 3.55 Pre. Close: 3.56
High: 3.73 Low: 3.49
Volume: 186,296 Market Cap: 242M
Seres Therapeutics Inc is a microbiome therapeutics platform company which is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.736 - 3.762 3.762 - 3.782
Low: 3.424 - 3.458 3.458 - 3.485
Close: 3.463 - 3.509 3.509 - 3.544

Technical analysis

as of: 2020-02-14 4:30:37 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 4.44     One year: 5.18
Support: Support1: 3.21    Support2: 2.85
Resistance: Resistance1: 3.80    Resistance2: 4.44
Pivot: 3.48
Moving Average: MA(5): 3.60     MA(20): 3.45
MA(100): 3.61     MA(250): 4.11
MACD: MACD(12,26): 0.03     Signal(9):
Stochastic oscillator: %K(14,3): 72.03     %D(3): 77.23
RSI: RSI(14): 50.22
52-week: High: 8.39  Low: 2.02  Change(%): -41.5
Average Vol(K): 3-Month: 21377  10-Days: 20064

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
MCRB has closed below upper band by 44.9%. Bollinger Bands are 27.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Seres Therapeutics Appoints Stephen Berenson as Chairman of its Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics announces the appointment of Stephen Berenson as Chairman of its Board of Directors.

Human Microbiome World Markets to 2023, Featuring Chr. Hansen, Enterome Bioscience, Seres Therapeutics, and Viome
DUBLIN, Nov. 25, 2019 /PRNewswire/ -- The "Growth Opportunities in Human Microbiome Market, Forecast to 2023" report has been added to's offering. This study highlights the growth opportunities, visioning scenarios, innovative business models/use cases, competitive…

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 70.01
Shares Float (M) 40.95
% Held by Insiders 10.32
% Held by Institutions 81.19
Shares Short (K) 3720
Shares Short P. Month (K)

Stock Financials

EPS -1.476
Book Value (p.s.) -0.460
PEG Ratio 0.02
Profit Margin -194.04
Operating Margin -194.24
Return on Assets (ttm) -39.1
Return on Equity (ttm)
Qtrly Rev. Growth -22.4
Gross Profit (p.s.) -0.967
Sales Per Share
EBITDA (p.s.) -0.929
Qtrly Earnings Growth
Operating Cash Flow (M) -49.81
Levered Free Cash Flow (M) -28.71

Stock Valuations

P/E -2.38
P/E Growth Ratio -0.01
P/BV -7.63
P/S 4.61
P/CF -4.93

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.